Search research articles
Contact Us
Filters
Showing results (51-60 of 89) with videos related to
Page
of 9
Sort By:
IJU Case Reports
|
May 5, 2022
Case Study: A Japanese patient with metastatic renal cell carcinoma who achieved long-term treatment-free survival with pembrolizumab and axitinib in the KEYNOTE-426 phase III trial of pembrolizumab and axitinib versus sunitinib
Koshiro Nishimoto, Suguru Shirotake, Yu Miyama, et al.
Case Reports in Oncology
|
January 2, 2026
Long-Term Control after Intermittent Reintroduction of Enfortumab Vedotin in Metastatic Urothelial Carcinoma: A Case Report
Kenta Fujii, Suguru Shirotake, Shohei Yamamura, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
June 3, 2026
Impact of Early Relative Dose Intensity on Survival in Patients Receiving Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Japanese Real-World Multicenter Study
Yuki Endo, Yuma Sakura, Go Kaneko, et al.
In Vivo (Athens, Greece)
|
December 31, 2024
Proactive Symptom Monitoring by Pharmacists Using a Cancer Patient Support App in Out-patient Oral Multi-kinase Inhibitor Therapy: Feasibility Study of a Small Patient Population
Maki Todo, Suguru Shirotake, G O Kaneko, et al.
Frontiers in Oncology
|
November 26, 2024
Case report: a rare clinical presentation of a difficult diagnosis of dedifferentiated liposarcoma showing leiomyosarcoma phenotype in the ileocecal region
Tomonori Kawasaki, Tomoaki Tashima, Kojiro Onohara, et al.
Japanese Journal of Clinical Oncology
|
February 2, 2022
Potential therapeutic effects of adjuvant chemotherapy after neoadjuvant chemotherapy for locally advanced muscle-invasive bladder cancer
Minami Omura, Eiji Kikuchi, Keisuke Shigeta, et al.
IJU Case Reports
|
November 7, 2022
Progressive metastatic pheochromocytoma induced by multiple endocrine neoplasia type 2A with a lethal outcome
Koshiro Nishimoto, Noriaki Lukas Santo, Masato Yonamine, et al.
Cancer Immunology, Immunotherapy : CII
|
February 4, 2025
Early detection of myocarditis caused by immune checkpoint inhibitor therapy with nivolumab and ipilimumab for advanced recurrent renal cell carcinoma
Maki Todo, Yodo Gatate, Shintaro Nakano, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
December 21, 2022
Clinical outcomes of nivolumab plus ipilimumab in patients with metastatic non-clear cell renal cell carcinoma: Real-world data from a Japanese multicenter retrospective study
Keita Izumi, Masaharu Inoue, Satoshi Washino, et al.
Urologic Oncology
|
November 19, 2025
Clinical outcomes of retreatment or discontinuation after interruption of nivolumab plus ipilimumab due to immune-related adverse events in metastatic renal cell carcinoma patients: A retrospective multicenter study
Yuta Sano, Masaharu Inoue, Satoshi Washino, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 89) with videos related to
Sort By:
Page
of 9
IJU Case Reports
|
May 5, 2022
Case Study: A Japanese patient with metastatic renal cell carcinoma who achieved long-term treatment-free survival with pembrolizumab and axitinib in the KEYNOTE-426 phase III trial of pembrolizumab and axitinib versus sunitinib
Koshiro Nishimoto, Suguru Shirotake, Yu Miyama, et al.
Case Reports in Oncology
|
January 2, 2026
Long-Term Control after Intermittent Reintroduction of Enfortumab Vedotin in Metastatic Urothelial Carcinoma: A Case Report
Kenta Fujii, Suguru Shirotake, Shohei Yamamura, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
June 3, 2026
Impact of Early Relative Dose Intensity on Survival in Patients Receiving Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Japanese Real-World Multicenter Study
Yuki Endo, Yuma Sakura, Go Kaneko, et al.
In Vivo (Athens, Greece)
|
December 31, 2024
Proactive Symptom Monitoring by Pharmacists Using a Cancer Patient Support App in Out-patient Oral Multi-kinase Inhibitor Therapy: Feasibility Study of a Small Patient Population
Maki Todo, Suguru Shirotake, G O Kaneko, et al.
Frontiers in Oncology
|
November 26, 2024
Case report: a rare clinical presentation of a difficult diagnosis of dedifferentiated liposarcoma showing leiomyosarcoma phenotype in the ileocecal region
Tomonori Kawasaki, Tomoaki Tashima, Kojiro Onohara, et al.
Japanese Journal of Clinical Oncology
|
February 2, 2022
Potential therapeutic effects of adjuvant chemotherapy after neoadjuvant chemotherapy for locally advanced muscle-invasive bladder cancer
Minami Omura, Eiji Kikuchi, Keisuke Shigeta, et al.
IJU Case Reports
|
November 7, 2022
Progressive metastatic pheochromocytoma induced by multiple endocrine neoplasia type 2A with a lethal outcome
Koshiro Nishimoto, Noriaki Lukas Santo, Masato Yonamine, et al.
Cancer Immunology, Immunotherapy : CII
|
February 4, 2025
Early detection of myocarditis caused by immune checkpoint inhibitor therapy with nivolumab and ipilimumab for advanced recurrent renal cell carcinoma
Maki Todo, Yodo Gatate, Shintaro Nakano, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
December 21, 2022
Clinical outcomes of nivolumab plus ipilimumab in patients with metastatic non-clear cell renal cell carcinoma: Real-world data from a Japanese multicenter retrospective study
Keita Izumi, Masaharu Inoue, Satoshi Washino, et al.
Urologic Oncology
|
November 19, 2025
Clinical outcomes of retreatment or discontinuation after interruption of nivolumab plus ipilimumab due to immune-related adverse events in metastatic renal cell carcinoma patients: A retrospective multicenter study
Yuta Sano, Masaharu Inoue, Satoshi Washino, et al.
Page
of 9